Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trials.

  • Soo R
  • Loh M
  • Mok T
 et al. 
  • 7


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Although interethnic differences in survival to cytotoxic chemotherapy in patients with non-small cell lung cancer exist, an analysis of survival outcomes based on ethnicity has not yet been fully evaluated systematically using large patient cohorts. Furthermore, recent trial results may be confounded by the use of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI).

Author-supplied keywords

  • Adult
  • Aged
  • Antineoplastic Agents
  • Antineoplastic Agents: therapeutic use
  • Asian Continental Ancestry Group
  • Asian Continental Ancestry Group: statistics & num
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Non-Small-Cell Lung: drug therapy
  • Carcinoma, Non-Small-Cell Lung: ethnology
  • Carcinoma, Non-Small-Cell Lung: mortality
  • Carcinoma, Non-Small-Cell Lung: pathology
  • Disease Progression
  • Disease-Free Survival
  • European Continental Ancestry Group
  • European Continental Ancestry Group: statistics &
  • Female
  • Health Status Disparities
  • Humans
  • Lung Neoplasms
  • Lung Neoplasms: drug therapy
  • Lung Neoplasms: ethnology
  • Lung Neoplasms: mortality
  • Lung Neoplasms: pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Time Factors
  • Treatment Outcome

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Ross a Soo

  • Marie Loh

  • Tony S Mok

  • Sai-Hong I Ou

  • Byoung-Chul Cho

  • Wee-Lee Yeo

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free